1. Medtech Insight
  2. >>Business

Financing: 2020 Ends On A High Note For Medtech

A look at financing activity across the medical device and in vitro diagnostics industries, October-December 2020

 
• By Deanna Kamienski and Maureen Riordan

During Q4, device company fundraising totaled $4.2bn; while in vitro diagnostic firms and research tools players raised $6.1bn.

MT-Money-Flow_1200x675

Fourth-quarter device financing reached $4.2bn, up from the previous quarter’s $3.3bn. The initial public offering category made up the most, accounting for $1.3bn, or 32%, of the Q4 total, followed by debt, which brought in an aggregate $1bn, or 25% of the Q4 financing dollars (see Exhibit 1).

Open Media

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Business

BD Names First CRO To Drive Commercial Overhaul As ’New BD‘ Strategy Builds Toward 2026 Launch

 
• By Shubham Singh

As BD refines its commercial model, it has also brought leadership transition to its finance organization. The company recently announced that executive vice president and chief financial officer Chris DelOrefice will depart BD effective Dec. 5.

Stryker Eyes Double-Digit Inari Growth Through Early 2026, With Global Expansion To Follow

 
• By Shubham Singh

Record Mako installations in the third quarter fueled growth across Stryker’s orthopedics portfolio, supporting higher revenue in the “Ortho Other” category. Executives said new product launches and software upgrades are broadening clinical applications.

BCI Maker INBRAIN Inks Deal With Microsoft To Explore Agentic AI Use For Monitoring Patients

 
• By Marion Webb

INBRAIN teamed up with Microsoft to apply agentic AI to analyze real-time brain data and eventually recommend programming like a “mini-neurologist,” said CEO Carolina Aguilar. It also seeks to enable scalable deployment of INBRAIN’s graphene-based technology and potential joined research.

Prosthetics: Firms Like Unhindr And Esper Shape Market On the Cusp of Great Change

 
• By Barnaby Pickering

The prosthetics market is evolving due to an increase in amputees from war and disease. Unhindr has developed a novel prostetic liner that can reduce the risk of further injury, while Esper is crafting advanced hand implants for Ukraine's front-line soldiers.

More from Medtech Insight

US FDA Appropriations Cut In Proposed Shutdown-Ending Agreement

 
• By Derrick Gingery

But the Senate’s reduction would not be as much as the House of Representatives and President Trump proposed earlier this year, which is likely a win for the agency.

Stryker Eyes Double-Digit Inari Growth Through Early 2026, With Global Expansion To Follow

 
• By Shubham Singh

Record Mako installations in the third quarter fueled growth across Stryker’s orthopedics portfolio, supporting higher revenue in the “Ortho Other” category. Executives said new product launches and software upgrades are broadening clinical applications.

Can Chatbots Treat Depression? FDA Advisers Urge Caution on Generative AI Tools

 
• By Elizabeth Orr

FDA advisers gave a cautious nod to the idea of using generative AI in mental healthcare during a Nov. 6 panel meeting, saying evidence-backed tools could help expand access – but warning that safety, oversight, and the irreplaceable human connection remain major unanswered questions.